U.S. Water Utilities Stock News

Arbe Robotics recently announced at CES 2026 that it is combining its automotive-grade ultra‑HD radar with NVIDIA’s accelerated computing to create an AI-based perception platform designed for hands-off, eyes-off driving, featuring over 20,000 detections per frame and more than 300 meters of range in varied weather conditions. A distinctive aspect of this development is how the dense radar point cloud, processed on NVIDIA’s in-vehicle computing, is being used to build AI-based occupancy...

Recent reaffirmations of positive ratings on Parker-Hannifin (PH) have put fresh attention on the industrial supplier, as analysts react to its steady financial results, dividends, and push into higher margin aerospace and motion control markets. See our latest analysis for Parker-Hannifin. The reaffirmed positive sentiment from analysts has arrived alongside solid recent momentum, with a 90 day share price return of 26.49% and a 1 year total shareholder return of 42.68%, suggesting interest...

Jefferies coverage initiation puts Goosehead Insurance in focus Jefferies has initiated coverage on Goosehead Insurance (GSHD), highlighting the company’s low-risk expansion through independent agency partnerships, its position in the property and casualty market, and a broker model focused on retention and commissions. See our latest analysis for Goosehead Insurance. Goosehead Insurance’s share price has moved to US$74.80, with a 90-day share price return of 9.09%. The 1-year total...

Q3 revenue surprise puts XPEL (XPEL) back in focus Recent attention on XPEL (XPEL) stems from its Q3 results, where revenue growth surpassed expectations while earnings per share came in below forecasts. This has prompted investors to reassess the trade off between sales momentum and profitability. See our latest analysis for XPEL. At a share price of $54.63, XPEL has climbed sharply in recent months, with a 90 day share price return of 61.18% and a 1 year total shareholder return of 39.35%...

Tecnoglass (TGLS) shares fell 5.5% after the company issued full-year EBITDA guidance that investors viewed as weak. At the same time, competitor Apogee Enterprises cut its outlook, reinforcing concerns about demand and cost pressures. See our latest analysis for Tecnoglass. At a share price of $51.23, Tecnoglass has a 1-day share price return of 6.86%, but a 90-day share price return decline of 17.46% and a 1-year total shareholder return loss of 30.55%, suggesting momentum has been fading...

If you are wondering whether Cal-Maine Foods at around US$75.46 is offering good value or asking too much, you are exactly who this review is written for. The stock has seen a 5.2% decline over the last 7 days, a 12.5% decline over 30 days, a 3.8% decline year to date and a 21.3% decline over 1 year. The 3 year and 5 year returns sit at 70.5% and 160.0% respectively. Recent attention on egg producers, shifts in consumer prices and ongoing discussion about food inflation have kept Cal-Maine...

For investors wondering whether Karman Holdings at around US$101.28 represents an opportunity or is already fully valued, this article walks through what the numbers may indicate about the stock. The share price has been active recently, with returns of 38.4% over the past 7 days, 58.9% over the past 30 days and 31.8% year to date. These movements can influence how you think about potential upside and risk. Recent coverage of Karman Holdings has focused on its listing on the NYSE and growing...

If you are wondering whether Walker & Dunlop is attractively priced at its current level, this article will walk through what the numbers are saying about its valuation. The stock last closed at US$62.36, with returns of 3.7% over the past week, 0.0% over the last month, 6.2% year to date, and a 29.9% decline over the past year. This sits against a 24.8% decline over three years and a 21.4% decline over five years. Recent attention on Walker & Dunlop has been shaped by ongoing market views...

Allot (ALLT) is back in focus after reports that its Cybersecurity as a Service business delivered about 60% year over year growth in annual recurring revenue in the third quarter of 2025. See our latest analysis for Allot. That SECaaS momentum comes alongside a $10.86 share price, a 7 day share price return of 10.48% and a 1 year total shareholder return of 50.21%, hinting at building momentum despite a 5.57% 1 day pullback. If Allot’s recent move has caught your eye, it could be a good...

Independent Bank (INDB) is back on investors’ radar after a recent share price move, with the stock closing at $76.20. That has some investors reassessing its valuation and recent financial profile. See our latest analysis for Independent Bank. The recent 2.6% 1 day share price return and 4.3% 7 day share price return sit within a wider pattern that includes a 16.3% 90 day share price return and a 26.6% 1 year total shareholder return. This suggests momentum has been building over the medium...

Recently, LandBridge reported its third-quarter 2025 results, completed the acquisition of 1918 Ranch projected to add about US$20,000,000 in EBITDA for fiscal 2026, and saw senior executives including the CFO and General Counsel increase their holdings through Class A share purchases. Alongside these moves, LandBridge’s subsidiary DBR Land Holdings LLC priced a US$500,000,000 senior notes offering and the company launched a 2,500,000-share Class A public offering, signaling active efforts...

Diversified Healthcare Trust (DHC) has set out a fresh course with three linked moves: large non core property sales, full repayment of its 2026 notes, and a broad reset of senior housing operations. See our latest analysis for Diversified Healthcare Trust. Those asset sales, debt repayment and senior housing changes arrive after a sharp shift in investor sentiment, with the share price at US$5.40 and a 90 day share price return of 33.33%, alongside a very large 3 year total shareholder...

Oculis Holding (NasdaqGM:OCS) is back on investor radars after its neuroprotective candidate Privosegtor received FDA breakthrough therapy designation for optic neuritis, supported by Phase 2 ACUITY data and advancement into registrational PIONEER trials. See our latest analysis for Oculis Holding. The FDA breakthrough therapy news has arrived alongside a 10.3% 7 day share price return and a 10.2% year to date share price return, while the 1 year total shareholder return of 17.8% and very...

Why the latest nPulse study update matters for Pulse Biosciences (PLSE) Pulse Biosciences (PLSE) just flagged a fresh catalyst, with late-breaking 6- and 12-month data from its first-in-human nPulse Cardiac Catheter Ablation System study set for presentation at the 31st Annual AF Symposium 2026. See our latest analysis for Pulse Biosciences. The upcoming AF Symposium data drop lands after a mixed year for investors, with a 9.93% year to date share price return to US$14.72, a 16.36% 3 month...

White Mountains Insurance Group recently completed a share repurchase of 64,064 shares for US$131.33 million and announced that its subsidiary Ark Insurance Holdings renewed its Outrigger Re Ltd. reinsurance sidecar for the 2026 underwriting year on terms similar to 2025, deploying US$70 million of third-party capital. The reduced size of Outrigger Re, alongside greater use of traditional quota share reinsurance, highlights an active recalibration of Ark’s capital and risk-transfer mix while...

In early January 2026, LifeMD announced it is now offering Novo Nordisk’s newly FDA-approved Wegovy (semaglutide) pill through its nationwide telehealth platform, expanding virtual access to an oral GLP-1 option for chronic weight management and cardiovascular health at cash-pay prices starting from US$149 per month for eligible patients. This move deepens LifeMD’s collaboration with Novo Nordisk and positions the company more firmly in the fast-growing obesity care segment by pairing...

Why NCR Voyix Is On Investors’ Radar Today NCR Voyix (VYX) is drawing attention after recent trading left the shares at $10.76, with mixed return figures that include a 9.1% gain year to date and a 21.9% decline over the past year. See our latest analysis for NCR Voyix. The recent 1 month share price return of 11.39% at a last close of $10.76 contrasts with a 1 year total shareholder return decline of 21.97%, which suggests short term momentum is improving while longer term returns remain...

Analyst upgrade sparks fresh attention on Landstar System Wells Fargo’s upgrade of Landstar System (LSTR) from Equal-Weight to Overweight, along with recent price target increases from other firms, has put the transportation specialist back on many investors’ watchlists. See our latest analysis for Landstar System. The recent analyst upgrade comes after a strong 90-day share price return of 22.81%, which contrasts with a 1-year total shareholder return decline of 6.92%. This suggests...

It's nice to see the Oxford Industries, Inc. ( NYSE:OXM ) share price up 13% in a week. But over the last three years...

Expro Group Holdings N.V.'s ( NYSE:XPRO ) price-to-earnings (or "P/E") ratio of 24.5x might make it look like a sell...

Build-A-Bear Workshop (NYSE:BBW) has had a great run on the share market with its stock up by a significant 26% over...

Phathom Pharmaceuticals recently completed a roughly US$130.0 million follow-on offering of common stock and pre-funded warrants, alongside new shelf registrations covering additional common stock and other securities, and issued earnings guidance indicating expected net revenues of about US$57.0 million–US$58.0 million for fourth quarter 2025 and US$174.5 million–US$175.5 million for full-year 2025, with operating profitability targeted in the second half of 2026 excluding stock-based...

If you are looking at First Horizon and wondering whether the current share price offers solid value, this article walks through what the numbers actually suggest about the stock. First Horizon shares last closed at US$24.75, with returns of 3.6% over 7 days, 8.5% over 30 days, 2.6% year to date, 23.3% over 1 year, 12.4% over 3 years and 90.4% over 5 years. These figures can influence how investors think about both opportunity and risk today. Recent market attention on US regional banks,...

Earlier this week at the CES 2026 technology conference in Las Vegas, artificial intelligence took center stage and boosted attention on software providers such as ZoomInfo Technologies, which offers go-to-market intelligence tools for sales and marketing teams. The renewed focus on AI at CES has highlighted how closely ZoomInfo’s long-term prospects may be tied to enterprise adoption of AI-driven sales and marketing workflows. We’ll now explore how this AI-focused momentum at CES could...